A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate how a person with liver impairment processes
and reacts to the study drug. Information about any side effects that may occur will also be
collected.